ALMR Financials

Income Statement
MetricQ3 2026Q2 2026
Revenue
33.5M
+14.0%
29.4M
Cost of Revenue
12.9M
+10.2%
11.7M
Gross Profit
20.6M
+16.5%
17.7M
Operating Expenses
35.8M
+14.5%
31.3M
R&D
16.2M
+17.0%
13.8M
SG&A
19.6M
+12.5%
17.4M
Operating Income
-15139000
-11.9%
-13532000
EBITDA
-13715000
-10.6%
-12398000
Net Income
-13342000
-1.1%
-13199000
EPS (Basic)
$-0.19
+13.6%
$-0.22
EPS (Diluted)
$-0.19
+13.6%
$-0.22
Shares (Diluted)
69.1M
+17.8%
58.7M
Alamar Biosciences (ALMR) — Financials